Medelis
2 SlideShares 8 Followers
Personal Information
Unternehmen/Arbeitsplatz
Nashville, TN United States
Branche
Medical / Health Care / Pharmaceuticals
Webseite
www.medelis.com
Info
Medelis is a boutique oncology CRO focused on phase I through phase III oncology trials in North America and Europe. We specialize in oncology, and our entire team has deep oncology trial experience and expertise.
Kontaktdetails
Tags
biotech oncology cro pharma biotechnology medelis pharmaceutical clinicalresearch contractresearch clinical research clinicaltrials health medicine pre-clinical contract trial pharmaceuticals patientsafety preclinical clinical research phase ii cytel phase i clinical trials adaptive trial dan-von-hoff cancer drug development trials phase i ii clinical_trial phase_i contract_research drug_development dan_von_hoff phase1
Mehr anzeigen
  • Präsentationen
  • Dokumente
  • Infografiken
Aktuellste Beliebteste SlideShares

Oncological Emergencies: Hypercalcaemia

Phil Mayor • Vor 15 Jahren

Patient Problem-Solving on the Web: How do Patients Use Web Forums to Cope with Chronic Disease? [4 1530 Aud Billman]

Gunther Eysenbach • Vor 15 Jahren

The Lost Art Of Phase I Oncology Trials

Medelis • Vor 15 Jahren

BioEntrepreneurship: The Business of Biotech

MaRS Discovery District • Vor 16 Jahren

Future trends and perspectives in modern pharmaceutical biotechnology

inemet • Vor 16 Jahren

Optimizing Preclinical Proof of Concept

MaRS Discovery District • Vor 16 Jahren

Open Data In Clinical Research

Martin Fenner • Vor 15 Jahren

Logistics and Practicalities of Phase I Clinical Research

MaRS Discovery District • Vor 16 Jahren

Clinical Trials Registry

biinoida • Vor 15 Jahren

The Cochrane Collaboration Colloquium: Global opportunities and challenges for trial registration: Update from the WHO International Clinical Trials Registry Platform

Cochrane.Collaboration • Vor 16 Jahren

Clinical Trials in India

vaatsalya • Vor 16 Jahren

Clinical Trials Strategy: The Clinical Development Plan

MaRS Discovery District • Vor 16 Jahren

Estimating the Maximum Safe Starting Dose for First-in-Human Clinical Trials

MaRS Discovery District • Vor 16 Jahren

How web 2.0 is changing medicine

Victor Castilla • Vor 17 Jahren

Patient Safety in Clinical Trials

Medelis • Vor 15 Jahren

Medicine 2.0 with the eye of a medical student blogger

Bertalan Mesko, MD • Vor 15 Jahren

Beyond the Business Plan - Managing unexpected risks in biotechnology business development

thinkBiotech • Vor 15 Jahren

Construction of Expertise in the Age of the Internet: Psychotropic Drug Knowledge in Consumer-Constructed Websites

Shannon Hughes • Vor 15 Jahren

Science and Web2.0

Ian Mulvany • Vor 16 Jahren